A mini-review of chemical and biological properties of polysaccharides from Momordica charantia

International Journal of Biological Macromolecules

Volumn 92, Issue , 2016, Pages 246-253

  Zhang, Fan ^a   Lin, Lihua ^a   Xie, Jianhua ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

Biological activities; Characterization; Momordica charantia; Physicochemical; Polysaccharides; Structure

Indexed keywords

POLYSACCHARIDE;

ALLOXAN-INDUCED DIABETES MELLITUS; ANTIDIABETIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; DIABETES MELLITUS; DRUG ISOLATION; DRUG MECHANISM; DRUG PURIFICATION; DRUG STRUCTURE; HUMAN; IMMUNOMODULATION; LIVER PROTECTION; LIVER TUMOR; MOMORDICA CHARANTIA; NONHUMAN; PHYSICAL CHEMISTRY; RADIATION PROTECTION; SARCOMA; SEPARATION TECHNIQUE; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANIMAL; CHEMICAL PHENOMENA; CHEMISTRY; ISOLATION AND PURIFICATION;

ANIMALS; CHEMICAL PHENOMENA; HUMANS; MOMORDICA CHARANTIA; POLYSACCHARIDES;

EID: 84978208727     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2016.06.101     Document Type: Article

References (87)

1. [1] Grover, J., Yadav, S., Pharmacological actions and potential uses of Momordica charantia: a review. J. Ethnopharmacol. 93:1 (2004), 123–132.
2. [2] Nagarani, G., Abirami, A., Siddhuraju, P., Food prospects and nutraceutical attributes of Momordica species: a potential tropical bioresources–a review. Food Sci. Hum. Wellness 3:3 (2014), 117–126.
3. [3] Xu, X., Shan, B., Liao, C.-H., Xie, J.-H., Wen, P.-W., Shi, J.-Y., Anti-diabetic properties of Momordica charantia L. polysaccharide in alloxan-induced diabetic mice. Int. J. Biol. Macromol. 81 (2015), 538–543.
4. [4] Ahmad, Z., Zamhuri, K.F., Yaacob, A., Siong, C.H., Selvarajah, M., Ismail, A., Hakim, M.N., In vitro anti-diabetic activities and chemical analysis of polypeptide-k and oil isolated from seeds of Momordica charantia (bitter gourd). Molecules 17:8 (2012), 9631–9640.
5. [5] Basch, E., Gabardi, S., Ulbricht, C., Bitter melon (Momordica charantia): a review of efficacy and safety. Am. J. Health Syst. Pharm. 60:4 (2003), 356–359.
6. [6] Hsu, C.-L., Fang, S.-C., Liu, C.-W., Chen, Y.-F., Inhibitory effects of new varieties of bitter melon on lipopolysaccharide-stimulated inflammatory response in RAW 264.7 cells. J. Funct. Foods 5:4 (2013), 1829–1837.
7. [7] Raman, A., Lau, C., Anti-diabetic properties and phytochemistry of Momordica charantia L. (Cucurbitaceae). Phytomedicine 2:4 (1996), 349–362.
8. [8] Shan, B., Xie, J.-H., Zhu, J.-H., Peng, Y., Ethanol modified supercritical carbon dioxide extraction of flavonoids from Momordica charantia L. and its antioxidant activity. Food Bioprod. Process. 90:3 (2012), 579–587.
9. [9] Manabe, M., Takenaka, R., Nakasa, T., Okinaka, O., Induction of anti-inflammatory responses by dietary Momordica charantia L. (bitter gourd). Biosci. Biotechnol. Biochem. 67:12 (2003), 2512–2517.
10. [10] Ganguly, C., De, S., Das, S., Prevention of carcinogen-induced mouse skin papilloma by whole fruit aqueous extract of Momordica charantia. Eur. J. Cancer Prev. 9:4 (2000), 283–288.
11. [11] Li, C.-J., Tsang, S.-F., Tsai, C.-H., Tsai, H.-Y., Chyuan, J.-H., Hsu, H.-Y., Momordica charantia extract induces apoptosis in human cancer cells through caspase-and mitochondria-dependent pathways. Evid. Based Complement. Altern. Med.(261971), 2012.
12. [12] Nerurkar, P., Ray, R.B., Bitter melon: antagonist to cancer. Pharm. Res. 27:6 (2010), 1049–1053.
13. [13] Chan, L.-L., Chen, Q.-X., Go, A.G., Lam, E.K.Y., Li, E.-T., Reduced adiposity in bitter melon (Momordica charantia) – fed rats is associated with increased lipid oxidative enzyme activities and uncoupling protein expression. J. Nutr. 135:11 (2005), 2517–2523.
14. [14] Puri, M., Kaur, I., Kanwar, R., Gupta, R., Chauhan, A., Kanwar, J., Ribosome inactivating proteins (RIPs) from Momordica charantia for anti-viral therapy. Curr. Mol. Med. 9:9 (2009), 1080–1094.
15. [15] Fang, E.F., Ng, T.B., Bitter gourd (Momordica charantia) is a cornucopia of health: a review of its credited antidiabetic, anti-HIV, and antitumor properties. Curr. Mol. Med. 11:5 (2011), 417–436.
16. [16] Zhang, L.-J., Liaw, C.-C., Hsiao, P.-C., Huang, H.-C., Lin, M.-J., Lin, Z.-H., Hsu, F.-L., Kuo, Y.-H., Cucurbitane-type glycosides from the fruits of Momordica charantia and their hypoglycaemic and cytotoxic activities. J. Funct. Foods 6 (2014), 564–574.
17. [17] Alam, S., Asad, M., Asdaq, S.M.B., Prasad, V.S., Antiulcer activity of methanolic extract of Momordica charantia L. in rats. J. Ethnopharmacol. 123:3 (2009), 464–469.
18. [18] Jayasooriya, A.P., Sakono, M., Yukizaki, C., Kawano, M., Yamamoto, K., Fukuda, N., Effects of Momordica charantia powder on serum glucose levels and various lipid parameters in rats fed with cholesterol-free and cholesterol-enriched diets. J. Ethnopharmacol. 72:1 (2000), 331–336.
19. [19] Zeng, K., He, Y.-N., Yang, D., Cao, J.-Q., Xia, X.-C., Zhang, S.-J., Bi, X.-L., Zhao, Y.-Q., New compounds from acid hydrolyzed products of the fruits of Momordica charantia L. and their inhibitory activity against protein tyrosine phosphatas 1B. Eur. J. Med. Chem. 81 (2014), 176–180.
20. [20] Yang, Z.-G., Shi, W.-Z., Shen, Z.-G., Zhang, Y.-P., Yang, J., Preventive Effect of Momordica charantia L. saponins on osteoporosis in ovariectomized rats. Food Sci. 31:7 (2010), 272–275.
21. [21] Horax, R., Hettiarachchy, N., Chen, P., Characteristics and functionality enhancement by glycosylation of bitter melon (Momordica charantia) seed protein. J. Food Sci. 79:11 (2014), C2215–C2221.
22. [22] Li, Z.-J., Chen, J.-C., Deng, Y.-Y., Song, N.-L., Yu, M.-Y., Zhou, L., Qiu, M.-H., Two new cucurbitane triterpenoids from immature fruits of Momordica charantia. Helv. Chim. Acta 98:10 (2015), 1456–1461.
23. [23] Zhang, B., Xie, C., Wei, Y., Li, J., Yang, X., Purification and characterisation of an antifungal protein MCha-Pr, from the intercellular fluid of bitter gourd (Momordica charantia) leaves. Protein Expr. Purif. 107 (2015), 43–49.
24. [24] Kenny, O., Smyth, T., Hewage, C., Brunton, N., Antioxidant properties and quantitative UPLC-MS analysis of phenolic compounds from extracts of fenugreek (Trigonella foenum-graecum) seeds and bitter melon (Momordica charantia) fruit. Food Chem. 141:4 (2013), 4295–4302.
25. [25] Duan, Z.-Z., Zhou, X.-L., Li, Y.-H., Zhang, F., Li, F.-Y., Qi, S.-H., Protection of Momordica charantia polysaccharide against intracerebral hemorrhage-induced brain injury through JNK3 signaling pathway. J. Recept. Signal Transduct. 35:6 (2015), 523–529.
26. [26] Gong, J.-J., Sun, F.-M., Li, Y.-H., Zhou, X.-L., Duan, Z.-Z., Duan, F.-G., Zhao, L., Chen, H.-S., Qi, S.-H., Shen, J.-G., Momordica charantia polysaccharides could protect against cerebral ischemia/reperfusion injury through inhibiting oxidative stress mediated c-Jun N-terminal kinase 3 signaling pathway. Neuropharmacology 91 (2015), 123–134.
27. [27] Li, J.-L., Wang, Y.-Q., Huang, J., Xu, X.-F., Xiang, C.-P., Characterization of antioxidant polysaccharides in bitter gourd (Momordica charantia L.) cultivars. J. Food Agric. Environ. 8:3&4 (2010), 117–120.
28. [28] Panda, B.C., Mondal, S., Devi, K.S.P., Maiti, T.K., Khatua, S., Acharya, K., Islam, S.S., Pectic polysaccharide from the green fruits of Momordica charantia (Karela): structural characterization and study of immunoenhancing and antioxidant properties. Carbohydr. Res. 401 (2015), 24–31.
29. [29] Tan, H.-F., Gan, C.-Y., Polysaccharide with antioxidant, α-amylase inhibitory and ACE inhibitory activities from Momordica charantia. Int. J. Biol. Macromol. 85 (2016), 487–496.
30. [30] Deng, Y.-Y., Yi, Y., Zhang, L.-F., Zhang, R.-F., Zhang, Y., Wei, Z.-C., Tang, X.-J., Zhang, M.-W., Immunomodulatory activity and partial characterisation of polysaccharides from Momordica charantia. Molecules 19:9 (2014), 13432–13447.
31. [31] Sun, X.-B., Jin, X.-Z., Pan, W., Wang, J.-P., Syntheses of new rare earth complexes with carboxymethylated polysaccharides and evaluation of their in vitro antifungal activities. Carbohydr. Polym. 113 (2014), 194–199.
32. [32] Guan, L.-X., Synthesis and anti-tumour activities of sulphated polysaccharide obtained from Momordica charantia. Nat. Prod. Res. 26:14 (2012), 1303–1309.
33. [33] Simpson, R., Morris, G.A., The anti-diabetic potential of polysaccharides extracted from members of the cucurbit family: a review. Bioactive Carbohydr. Dietary Fibre 3:2 (2014), 106–114.
34. [34] Wu, J.-D., Gan, G.-S., Chen, H.-M., Li, H.-M., Studies on the enzyme hydrolysis of soluble polysaccharide from Momordica charantia. J. Anhui Agric. Sci. 33:1 (2005), 73–74.
35. [35] Cheng, S., Cui, Q.-X., Wang, Y., Extraction and determination of water-soluble polysaccharide of Momordica charantia. J. Zhengzhou Grain Coll. 21:2 (2000), 53–59.
36. [36] Fan, T., Hu, J.-G., Fu, L.-D., Zhang, L.-J., Optimization of enzymolysis-ultrasonic assisted extraction of polysaccharides from Momordica charabtia L. by response surface methodology. Carbohydr. Polym. 115 (2015), 701–706.
37. [37] Zhou, R., Tu, N.-Y., Cong, M., Kan, G.-S., Ren, D.-M., Chen, H.-M., Purification and hepatoprotective effect of Momordica polysaccharides. Food Sci. Technol. 38:2 (2013), 173–176.
38. [38] Zhang, L.-F., Zhang, M.-W., Huang, W., Zhang, Y., Zhang, R.-F., Wei, Z.-C., Optimization on cellulase and ultrasonic wave assisted extraction technology of Momordica charantia polysaccharides. Trans. Chin. Soc. Agric. Mach. 41:11 (2010), 142–147.
39. [39] Yuan, Y., Zhang, H., Chen, G.-Y., Study on the conditions of extracting polysaccharides in Momordica charantia L. by means of microwave. J. Hainan Normal Univ. (Nat. Sci.) 21:1 (2008), 44–46.
40. [40] Wu, L.-W., Ke, L.-J., Huang, X.-N., Liu, S.-T., Chen, H., Rao, P.-F., Seperation and characterization of the active ingredients of Momordica charantia L. and their protective and repairing effect on HIT-T15 cells damaged by alloxan in vitro. J. Chin. Inst. Food Sci. Technol. 6:4 (2006), 64–68.
41. [41] Aziz, M., Roy, J., Sarker, M., Yusof, Y., Isolation and use of bitter gourd polysaccharide in formulating dietetic soft drinks. Afr. J. Agric. Res. 6:23 (2011), 5314–5319.
42. 2 process. Carbohydr. Polym. 84:1 (2011), 255–261.
43. [43] Staub, A., Removal of protein-sevag method. Methods Carbohydr. Chem. 5:2 (1965), 5–6.
44. [44] Liu, X., Chen, T., Hu, Y., Li, K.-X., Yan, L.-S., Catalytic synthesis and antioxidant activity of sulfated polysaccharide from Momordica charantia L. Biopolymers 101:3 (2014), 210–215.
45. [45] Wu, X.-G., Wang, Z.-G., Cai, Y., Yang, Y., Wang, M., Extraction, isolation, purification and composition of Momordica charantia polysaccharide. Chin. J. Bioprocess Eng. 9:1 (2011), 19–23.
46. [46] Kumar, G.S., Vijayalakshmi, B., Salimath, P., Effect of bitter gourd and spent turmeric on constituents of glycosaminoglycans in different tissues in streptozotocin induced diabetic rats. Mol. Cell. Biochem. 286:1-2 (2006), 53–58.
47. [47] Cheng, H.-R., Feng, S.-L., Xue, X.-J., Li, Q.-Q., Zhou, Y.-H., Ding, C.-B., Structural characterization and antioxidant activities of polysaccharides extracted from Epimedium acuminatum. Carbohydr. Polym. 92:1 (2013), 63–68.
48. [48] Ali, L., Azad Khan, A., Rouf Mamun, M., Mosihuzzaman, M., Nahar, N., Nur-E-Alam, M., Rokeya, B., Studies on hypoglycemic effects of fruit pulp, seed, and whole plant of Momordica charantia on normal and diabetic model rats. Planta Med. 59:5 (1993), 408–412.
49. [49] Omoregbe, R., Ikuebe, O., Ihimire, I., Antimicrobial activity of some medicinal plants extracts on Escherichia coli, Salmonella paratyphi and Shigella dysenteriae. Afr. J. Med. Med. Sci. 25:4 (1996), 373–375.
50. [50] Chen, H.-M., Li, H.-X., Kan, G.-S., Ren, D.-M., Correlation study between antioxidant activity and lowering blood glucose of Momordica polysaccharide. Sci. Technol. Food Ind. 33:18 (2012), 349–351.
51. [51] Ru, Y., Xu, H., Chen, H.-M., Modification of polysaccharide from Momordica charantia L. and its antioxidant activities. J. Food Saf. Qual. 6:8 (2015), 2917–2923.
52. 2-induced oxidative stress in RAW264.7 cells. Int. J. Biol. Macromol. 80 (2015), 410–417.
53. [53] Wang, Z.-J., Xie, J.-H., Shen, M.-Y., Tang, W., Wang, H., Nie, S.-P., Xie, M.-Y., Carboxymethylation of polysaccharide from Cyclocarya paliurus and their characterization and antioxidant properties evaluation. Carbohydr. Polym. 136 (2016), 988–994.
54. [54] Xie, J.-H., Wang, Z.-J., Shen, M.-Y., Nie, S.-P., Gong, B., Li, H.-S., Zhao, Q., Li, W.-J., Xie, M.-Y., Sulfated modification, characterization and antioxidant activities of polysaccharide from Cyclocarya paliurus. Food Hydrocoll. 53 (2016), 7–15.
55. [55] Xie, J.-H., Zhang, F., Wang, Z.-J., Shen, M.-Y., Nie, S.-P., Xie, M.-Y., Preparation, characterization and antioxidant activities of acetylated polysaccharides from Cyclocarya paliurus leaves. Carbohydr. Polym. 133 (2015), 596–604.
56. [56] Chen, H.-M., Hang, T.-J., Tian, X.-Y., Study on antioxidant activity of Momordica polysaccharide. Food Sci. Technol. 34:6 (2009), 166–169.
57. [57] Zou, C., Du, Y.-M., Li, Y., Yang, J.-H., Feng, T., Zhang, L., Kennedy, J.F., Preparation of lacquer polysaccharide sulfates and their antioxidant activity in vitro. Carbohydr. Polym. 73:2 (2008), 322–331.
58. [58] Danaei, G., Finucane, M.M., Lu, Y., Singh, G.M., Cowan, M.J., Paciorek, C.J., Lin, J.K., Farzadfar, F., Khang, Y.-H., Stevens, G.A., National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 378:9785 (2011), 31–40.
59. [59] Grover, J., Yadav, S., Vats, V., Medicinal plants of India with anti-diabetic potential. J. Ethnopharmacol. 81:1 (2002), 81–100.
60. [60] Joseph, B., Jini, D., Antidiabetic effects of Momordica charantia (bitter melon) and its medicinal potency. Asian Pac. J. Trop. Dis. 3:2 (2013), 93–102.
61. [61] Modak, M., Dixit, P., Londhe, J., Ghaskadbi, S., Devasagayam, T.P.A., Indian herbs and herbal drugs used for the treatment of diabetes. J. Clin. Biochem. Nutr. 40:3 (2007), 163–173.
62. [62] Palamthodi, S., Lele, S., Nutraceutical applications of gourd family vegetables: Benincasa hispida, Lagenaria siceraria and Momordica charantia. Biomed. Prev. Nutr. 4:1 (2014), 15–21.
63. [63] Ahmed, I., Lakhani, M., Gillett, M., John, A., Raza, H., Hypotriglyceridemic and hypocholesterolemic effects of anti-diabetic Momordica charantia (karela) fruit extract in streptozotocin-induced diabetic rats. Diab. Res. Clin. Pract. 51:3 (2001), 155–161.
64. [64] Nkambo, W., Anyama, N., Onegi, B., In vivo hypoglycemic effect of methanolic fruit extract of Momordica charantia L. Afr. Health Sci. 13:4 (2014), 933–939.
65. [65] Virdi, J., Sivakami, S., Shahani, S., Suthar, A., Banavalikar, M., Biyani, M., Antihyperglycemic effects of three extracts from Momordica charantia. J. Ethnopharmacol. 88:1 (2003), 107–111.
66. [66] Xu, B., Dong, Y., Zhang, H.-H., Cui, H.-L., Lu, Q., The antihyperglycemic effects of polysaccharide from Momordica charantia in STZ-induced diabetic mice. Acta Nutr. Sin. 28:5 (2006), 401–403.
67. [67] Dong, Y., Zhang, H.-H., Studies on components with antihyperglycemic effect of Momoraica charantia L. polysaccharides. Acta Nutr. Sin. 30:1 (2008), 54–56.
68. [68] He, X.-Y., Liu, Z.-H., Study on HTS anti-diabetic antagonists from Momordica charantia L. Food Sci. 28:2 (2007), 313–316.
69. [69] Dorman, H., Deans, S., Antimicrobial agents from plants: antibacterial activity of plant volatile oils. J. Appl. Microbiol. 88:2 (2000), 308–316.
70. [70] Zhang, P.-P., Liu, J.-F., Wang, C.-L., Ye, Y.-T., Xie, J.-H., Study on the antimicrobial activities of the extracts from Momordica charantia L. Nat. Prod. Res. Dev. 20:4 (2008), 721–724.
71. [71] Zhang, W.-B., Wei, W.-L., Li, H.-R., Study on ultrasonic extraction and antibacterial activity of Polysaccharides from bitter gourd. Lishizhen Med. Mater. Med. Res. 22:7 (2011), 1676–1677.
72. [72] Cai, Y., Liu, M., Wu, X.-G., Wang, Z.-G., Liang, C., Yang, Y., Study on the antitumor and immune-stimulating activity of polysaccharide from Momordica charantia. Pharm. Clin. Res. 18:2 (2010), 131–134.
73. [73] Meera, S., Nagarjuna, C.G., Antistress and immunomodulatory activity of aqueous extract of Momordica charantia. Pharmacogn Mag. 5:19 (2009), 69–73.
74. [74] Xie, J.-H., Tang, W., Jin, M.-L., Li, J.-E., Xie, M.-Y., Recent advances in bioactive polysaccharides from Lycium barbarum L., Zizyphus jujuba Mill, Plantago spp., and Morus spp.: Structures and functionalities. Food Hydrocoll. 60 (2016), 148–160.
75. [75] Liu, Z., Jiao, Y., Wang, Y., Zhou, C., Zhang, Z., Polysaccharides-based nanoparticles as drug delivery systems. Adv. Drug Deliv. Rev. 60:15 (2008), 1650–1662.
76. [76] Xie, J.-H., Jin, M.-L., Morris, G.A., Zha, X.-Q., Chen, H.-Q., Yi, Y., Li, J.-E., Wang, Z.-J., Gao, J., Nie, S.-P., Advances on bioactive polysaccharides from medicinal plants. Crit. Rev. Food Sci. Nutr. 56:sup1 (2016), S60–S84.
77. [77] Iguchi, C., Nio, Y., Takeda, H., Yamasawa, K., Hirahara, N., Toga, T., Itakura, M., Tamura, K., Plant polysaccharide PSK: cytostatic effects on growth and invasion; modulating effect on the expression of HLA and adhesion molecules on human gastric and colonic tumor cell surface. Anticancer Res. 21:2A (2000), 1007–1013.
78. [78] Khan, F., Ahmad, S.R., Polysaccharides and their derivatives for versatile tissue engineering application. Macromol. Biosci. 13:4 (2013), 395–421.
79. [79] Petrovsky, N., Aguilar, J.C., Vaccine adjuvants: current state and future trends. Immunol. Cell Biol. 82:5 (2004), 488–496.
80. [80] Zhang, Y., Li, S., Wang, X., Zhang, L., Cheung, P.-C., Advances in lentinan: isolation, structure, chain conformation and bioactivities. Food hydrocoll. 25:2 (2011), 196–206.
81. [81] Bisen, P., Baghel, R.K., Sanodiya, B.S., Thakur, G.S., Prasad, G., Lentinus edodes: a macrofungus with pharmacological activities. Curr. Med. Chem. 17:22 (2010), 2419–2430.
82. [82] Hamuro, J., Anticancer immunotherapy with perorally effective lentinan. Gan to Kagaku Ryoho 32:8 (2005), 1209–1215.
83. [83] Zhang, C., Sun, X.-B., Song, A.-R., Pan, W., Han, Z.-J., Ding, L.-J., Wang, J.-P., Synthesis and antiproliferative effect on esophagus cancer cells and interaction with DNA of Eu-Momordica charantia L. polysaccharide complex. Food Sci. 34:17 (2013), 327–332.
84. [84] Li, Z.-T., Zhang, J., Xie, J., Sun, R.-G., The inhibition effect of two different Momordica charantia polysaccharides on the proliferation of human leukemia cell in vitro. J. Shangxi Normal Univ. (Nat. Sci. Ed.) 41:2 (2013), 76–81.
85. [85] Huang, X., Nie, S., The structure of mushroom polysaccharides and their beneficial role in health. Food Funct. 6:10 (2015), 3205–3217.
86. [86] Wu, J., Zhou, J.-X., Lang, Y.-G., Yao, L., Xu, H., Shi, H.-B., Xu, S.-D., A polysaccharide from Armillaria mellea exhibits strong in vitro anticancer activity via apoptosis-involved mechanisms. Int. J. Biol. Macromol. 51:4 (2012), 663–667.
87. [87] Jin, M.-L., Zhao, K., Huang, Q.-S., Shang, P., Structural features and biological activities of the polysaccharides from Astragalus membranaceus. Int. J. Biol. Macromol. 64 (2014), 257–266.